A detailed history of Bit Capital Gmb H transactions in Argenx Se stock. As of the latest transaction made, Bit Capital Gmb H holds 4,032 shares of ARGX stock, worth $2.56 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
4,032
Previous 3,301 22.14%
Holding current value
$2.56 Million
Previous $1.79 Billion 38.58%
% of portfolio
0.2%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$520.52 - $638.33 $380,500 - $466,619
731 Added 22.14%
4,032 $2.48 Billion
Q3 2024

Feb 12, 2025

SELL
$434.22 - $551.9 $604,868 - $768,796
-1,393 Reduced 29.68%
3,301 $1.79 Billion
Q1 2024

Feb 12, 2025

BUY
$356.95 - $413.29 $1.68 Million - $1.94 Million
4,694 New
4,694 $1.85 Billion

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $35.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Bit Capital Gmb H Portfolio

Follow Bit Capital Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Bit Capital Gmb H with notifications on news.